Sartorius Acquires Umetrics and Bioscience

Germany: Biopharmaceutical Industry Sartorius Acquires Umetrics and Bioscience

04.04.2017Editor: Alexander Stark

Sartorius acquired through its subgroup Sartorius Stedim Biotech the company MKS Instruments AB (Umetrics) based in Malmö, Sweden. In addition, Sartorius completed the acquisition of U.S.-based Essen Bioscience signed on March 3, 2017, after receiving antitrust clearance.

Related Company

Sartorius Corporate Administration GmbH

Dr. Joachim Kreuzburg, CEO and Executive Board Chairman of Sartorius AG
(Source: Sartorius)

Goettingen/Germany — Umetrics is a specialist in data analytics software for modeling and optimizing biopharmaceutical development and manufacturing processes. The company has already been cooperating with Sartorius for around five years and, in 2017, plans to generate full-year sales revenue of around $ 15 million and a significant double-digit operating profit margin. Sartorius purchased the company for $ 72.5 million from the U.S. MKS Instruments Group.

By acquiring Essen Bioscience, the Sartorius Lab Products & Services Division is expanding its portfolio in bioanalytics, which it entered last year by acquiring Intelli Cyt, a cell screening specialist. Essen Bioscience is headquartered in Ann Arbor, Michigan, USA. For the current fiscal year, the company expects to generate annual sales revenue of around $ 60 million and a strong double-digit operating profit margin.

Guidance raised for fiscal 2017

For the Lab Products & Services Division, Group management projects that, considering the Essen Bioscience acquisition and assuming an overall stable economic environment, the company expects an increase of about 20 % to 24 % (previously about 6 % to 10 %). For the Bioprocess Solutions Division, Sartorius expects that sales will grow by about 9 % to 13 %.

“Through the five companies that we have acquired over the past nine months, we have further extended the footprint of both our Group divisions in biopharmaceutical applications considerably. Even though the market environment has leveled off to normal growth levels as expected, we are well on track to achieve our increased annual targets,” said Group CEO Joachim Kreuzburg.

Unfold for details of your consent

Stand vom 23.03.2021

Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.

Consent to the use of data for promotional purposes

I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planckstr. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here

Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.

In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here.

Right of revocation

I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://support.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.

(ID:44615371)

Germany: Biopharmaceutical Industry Sartorius Acquires Umetrics and Bioscience

Guidance raised for fiscal 2017

Subscribe to the newsletter now

Don't Miss out on Our Best Content

Consent to the use of data for promotional purposes